-
441
Overweight: atherogenesis risk marker in children between 8 and 9 years
Published 2008-12-01“…Six children were diagnosed with metabolic syndrome.…”
Get full text
Article -
442
Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
Published 2020-01-01“…The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it is evident that they share several common features. …”
Get full text
Article -
443
Probiotics, metabolism and the functional condition of cardio-vascular system
Published 2016-08-01“…Obtained data demonstrate that intake of certain probiotic strains may be applied as a successful treatment of atherosclerosis, systemic hypertension, metabolic syndrome and heart failure. Conclusion. Microbiome may be involved in development of cardio-vascular diseases and atherosclerosis due to metabolic symbiosis with the host. …”
Get full text
Article -
444
Role of PPARα and Its Agonist in Renal Diseases
Published 2010-01-01“…In clinical application, PPAR-α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. This paper focuses on signaling pathways, ligand selectivity, and physio-pathological roles of PPARα in kidney diseases and the therapeutic utility of PPARα modulators in the treatment of diabetes and inflammation-induced nephropathy. …”
Get full text
Article -
445
Antiseizure medications and their differing effects on cardiovascular risk
Published 2025-03-01“…The overall atherosclerotic risk picture is more complex due to indirect effects such as neuroendocrine function and the metabolic syndrome. Large scale data shows an evolving understanding of cardiovascular risk. …”
Get full text
Article -
446
RETRACTED ARTICLE: Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review
Published 2024-08-01“…This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors—hypertension, dyslipidemia, diabetes—as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. …”
Get full text
Article -
447
-
448
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Published 2025-01-01“…Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is closely associated with metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. However, effective treatment strategies for NAFLD are still lacking. …”
Get full text
Article -
449
From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines
Published 2016-01-01“…Adipokines play a significant role in the metabolic syndrome and in cardiovascular diseases, have implications in regulating insulin sensitivity and inflammation, and have significant effects on growth and reproductive function. …”
Get full text
Article -
450
Who will carry out the tests that would be necessary for proper safety evaluation of food emulsifiers?
Published 2019-06-01“…Moreover, it has recently been suggested that emulsifier consumption might contribute to the development of metabolic syndrome and can promote colitis-associated colorectal cancer also. …”
Get full text
Article -
451
Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity
Published 2018-01-01“…Hence, the aim of this case report was to describe the clinical presentation and weight management of a 31-year-old male patient with spinal muscular atrophy type III, class I obesity, and metabolic syndrome treated for 1 year by means of a personalised multistep cognitive-behavioural treatment for obesity. …”
Get full text
Article -
452
On the development of diagnostic support algorithms based on CPET biosignals data via machine learning and wavelets
Published 2025-01-01“…This article introduces an algorithm that builds upon an earlier methodology to assess biosignals acquired through cardiopulmonary exercise testing (CPET) for identifying metabolic syndrome (MS), heart failure (HF), and healthy individuals (H). …”
Get full text
Article -
453
The role of immunity in insulin resistance in patients with polycystic ovary syndrome
Published 2025-01-01“…Polycystic ovary syndrome (PCOS) is a prevalent disorder of the endocrine system with significant clinical implications, often leading to health complications related to adipose tissue accumulation, including obesity, insulin resistance (IR), metabolic syndrome, and type 2 diabetes mellitus. While the precise pathogenesis of PCOS remains unclear, it is now recognized that genetic, endocrine, and metabolic dysregulations all contribute significantly to its onset. …”
Get full text
Article -
454
Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease
Published 2014-01-01“…This low-grade chronic inflammation is thought to link obesity to insulin resistance and the associated comorbidities of metabolic syndrome such as dyslipidemia and hypertension, which increase risk of type 2 diabetes and cardiovascular disease. …”
Get full text
Article -
455
Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD)
Published 2014-01-01“…NAFLD related with obesity, type 2 diabetes mellitus and metabolic syndrome. Insulin resistance and oxidative stress have important role in molecular pathogenesis of NAFLD. …”
Get full text
Article -
456
The Importance of Magnesium in Clinical Healthcare
Published 2017-01-01“…Level I evidence supports the use of magnesium in the prevention and treatment of many common health conditions including migraine headache, metabolic syndrome, diabetes, hyperlipidemia, asthma, premenstrual syndrome, preeclampsia, and various cardiac arrhythmias. …”
Get full text
Article -
457
The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
Published 2013-01-01“…We conducted a search of PubMed and MEDLINE database, using the term DPP-4 inhibitor in combination with the following terms: metabolic syndrome, hypertension, dyslipidemia, insulin resistance, obesity, and CVD. …”
Get full text
Article -
458
Vascular Remodeling in Experimental Hypertension
Published 2005-01-01“…This review will provide an overview of the evidence, explaining some of the pathophysiologic mechanisms participating in the development of the vascular remodeling, in experimental models of hypertension, with special reference to the findings in spontaneously hypertensive rats as a model of essential hypertension, and in fructose-fed rats as a model of secondary hypertension, in the context of the metabolic syndrome. The understanding of the mechanisms producing the vascular alterations will allow the development of novel pharmacological tools for vascular protection in hypertensive disease.…”
Get full text
Article -
459
Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review
Published 2025-01-01“…Interestingly, several previous studies have examined the potential relation of insomnia to metabolic syndrome and hyperlipidemia and found that insomnia was associated with elevated plasma cholesterol and triglyceride concentrations. …”
Get full text
Article -
460
The role of insulin signaling with FOXO and FOXK transcription factors
Published 2024-10-01“…In both mice and humans, excessive dietary intake can lead to insulin resistance in various organs, ultimately displaying metabolic syndrome and type 2 diabetes. Insulin signals require thorough regulation to maintain metabolism across diverse environments. …”
Get full text
Article